1. P1098: OUTCOME OF FOLLICULAR LYMPHOMA PATIENTS IN MAINTENANCE TREATMENT WITH ANTICD20 MONOCLONAL ANTIBODIES IN SARS-COV2 ERA: RESULTS FROM A MULTICENTER, RETROSPECTIVE- PROSPECTIVE ITALIAN STUDY. (23rd June 2022) Authors: Castellino, A.; Castellino, C.; Boccomini, C.; Clerico, M.; Nicoli, P.; Vanazzi, A.; Fanelli, F.; Perrone, T.; Marchesi, F.; Cocito, F.; Merli, M.; Bigliardi, S.; Mecacci, B.; Bozzoli, V.; Margiotta-Casaluci, G.; Meli, E.; Anastasia, A.; Farina, L.; Annibali, O.; Gottardi, D. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 988 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PB2132: COPANLISIB PLUS RITUXIMAB-BENDAMUSTINE FOR RELAPSED-REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RECRUITMENT UPDATE ON AN ONGOING PHASE II TRIAL OF THE FONDAZIONE ITALIANA LINFOMI (FIL_COPA-RB). (23rd June 2022) Authors: Novo, M.; Castellino, A.; Chiappella, A.; Ciccone, G.; Balzarotti, M.; Arcari, A.; Scarpa, E.; Tucci, A.; Di Renzo, N.; Tarantini, G.; Gini, G.; Moretti, M.; Mannina, D.; Di Rocco, A.; Spina, M.; Vitolo, U. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 2003 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Retrospective analysis on R‐DHAP/OX and ASCT as salvage treatment for relapsed/refractory high‐risk follicular lymphoma. (June 2017) Authors: Ghione, P.; Cavallo, F.; Visco, C.; Chen, Z.; Nicolosi, M.; Castellino, A.; Tisi, M.C.; Dogliotti, I.; Boccadoro, M.; Leonard, J.P.; Vitolo, U.; Martin, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗